Cite

HARVARD Citation

    De Baère, T. et al. (n.d.). PH-0159: NANORAY-103: Phase I/II trial of NBTXR3 activated by SBRT in patients with HCC and liver metastases. Radiotherapy and oncology. pp. S74-S75. [Online]. 
  
Back to record